| Similar Articles |
|---|
 |
Nurse Practitioner
September 2010
Sarah E. Gay |
An inside view of Venous Thromboembolism As the U.S. population ages, the medical and economic impact of VTE is expected to increase. The nurse practitioner plays a key role in providing prevention and intervention.   |
American Family Physician
January 15, 2004
Mark H. Ebell |
Suspected Pulmonary Embolism: Part I How can the history and physical examination help physicians diagnose pulmonary embolism? |
American Family Physician
November 15, 2005
William E. Cayley |
Diagnosing the Cause of Chest Pain Distinguishing between serious and benign causes of chest pain is imperative, and diagnostic and prognostic questions are important in making this determination. |
Nursing
April 2009
Pruitt & Lawson |
What You Need to Know About Venous Thromboembolism Do you know how to recognize and respond to this potentially life-threatening emergency? |
American Family Physician
June 15, 2004
Ramzi & Leeper |
DVT and Pulmonary Embolism: Part II. Treatment and Prevention Evaluation for thrombophilias and other secondary causes of venous thromboembolic disease, presents an evidence-based approach to the treatment of DVT and PE, and reviews current recommendations for prevention of venous thromboembolism. |
American Family Physician
April 15, 2005
Karnani, Reisfield & Wilson |
Evaluation of Chronic Dyspnea Chronic dyspnea is defined as dyspnea lasting more than one month. Information is presented on diagnosis, assessment and treatment for chronic dyspnea. |
American Family Physician
May 1, 2001
Trenton D. Nauser & Steven W. Stites |
Diagnosis and Treatment of Pulmonary Hypertension Regardless of the etiology, unrelieved pulmonary hypertension can lead to right-sided heart failure. Signs and symptoms of pulmonary hypertension are often subtle and nonspecific... |
American Family Physician
December 1, 2004
Steven A. Dosh |
Diagnosis of Heart Failure in Adults The evaluation of symptomatic patients with suspected heart failure is directed at confirming the diagnosis, determining the cause, identifying concomitant illnesses, establishing the severity of heart failure, and guiding therapy. |
American Family Physician
March 15, 2002
Khalid Almoosa |
Is Thrombolytic Therapy Effective for Pulmonary Embolism? No evidence from clinical trials proves that thrombolytic therapy reduces the recurrence rate of pulmonary embolism or affects mortality in hemodynamically stable patients... |
Nursing
December 2009
Vincent M. Vacca |
On the Alert for Pulmonary Arterial Hypertension Progressive and ultimately fatal, pulmonary arterial hypertension is a disease of the pulmonary arterial vasculature with no known cause. |
American Family Physician
November 1, 2003
Zoorob & Campbell |
Acute Dyspnea in the Office Shortness of breath, or dyspnea, is a common problem in the outpatient primary care setting. Establishing a diagnosis can be challenging because dyspnea appears in multiple diagnostic categories. Underlying disorders range from the relatively simple to the more serious. |
American Family Physician
April 15, 2002
Amy R. Sparks |
Imaging of Abdominal Aortic Aneurysms Given the high rate of morbidity and mortality associated with abdominal aortic aneurysms, accurate diagnosis and preoperative evaluation are essential for improved patient outcomes... |
American Family Physician
August 1, 2005
Wattendorf & Hadley |
Family History: The Three-Generation Pedigree The three-generation pedigree provides a pictorial representation of diseases within a family and is the most efficient way to assess hereditary influences on disease. |
Nursing
August 2010
Bartley & Shiflett |
Handle older trauma patients with care Your comprehensive understanding of how age-related changes can affect outcomes during and after trauma will help your patients recover to the fullest extent possible. |
Managed Care
September 2006
Caprini & Hyers |
Compliance With Antithrombotic Guidelines: Current Practice, Barriers, and Strategies For Improvement Deeply held, but not evidence-based, concerns about the possible risks of pharmacologic prophylaxis leave many patients at risk for DVT. |
D-Lib
Jan/Feb 2015
Slaughter et al. |
Enabling Living Systematic Reviews and Clinical Guidelines through Semantic Technologies We provide a brief review of the related literature on various efforts to produce semantic technologies for sharing and reusing content from clinical investigations. |
Pharmaceutical Executive
November 1, 2012
Sue Barrowcliffe |
Real World Insights Commercial teams as well as patients can benefit from managed access programs, which are designed to provide access to medicines outside of the clinical and commercial setting, for patients who have no other available treatment options. |
Pharmaceutical Executive
November 1, 2014
William Looney |
Dane in America Jesper Hoiland, Novo Nordisk's President for North America, assesses the challenges and opportunities during his first year at the helm of the diabetes franchise leader's biggest affiliate market. |
Pharmaceutical Executive
March 1, 2013
Ken Getz |
Building Clinical Trial Awareness for Patients: Why Not Try the Pharmacist? The author explains how building a stakeholder outreach agenda around the community pharmacist can lead to a better outcome in managing the complex ins and outs of a trial protocol. |
Pharmaceutical Executive
April 1, 2014
William Looney |
The Trials of Commerce Four commercial line executives serve as our jury of peers on what's in store for the future of pharma, and discuss the changing criteria for market success, from drugs to consumer products to vaccines. |
Pharmaceutical Executive
March 1, 2014
William Looney |
The Call to Community: A Conversation with Dr. David Nash Population health is the foundation for much of what is truly new in US health reform. For big Pharma, it represents yet another escalation in expectations. |
Pharmaceutical Executive
August 1, 2013
William Looney |
Succinctly Shire: An Interview with CEO Flemming Ornskov Shire's new CEO has a simple strategy for success: Set the pace on specialty medicines, spread the positive buzz and momentum of a growth stock, and seize the opportunity to innovate. |
Pharmaceutical Executive
July 10, 2014
Ben Comer |
WebMD: The Patient Value Equation For WebMD CEO David Schlanger, connecting patients with physicians through a robust digital platform delivers the winning formula necessary to achieve quality of care, cost savings, and better health outcomes. |
